Investigative sites for groundbreaking trials
By leveraging relationships with neurology centers nationwide, Meridian provides greater access to special populations. These sites are led by physicians that fully support clinical research, and several of Meridian’s principal investigators are leading regional providers for neurological disorders like Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.
Meridian’s neurology sites also have long-established patient databases featuring sensitive and hard-to-recruit cohorts, which is particularly valuable for rare disease research programs.
Beyond these neurology sites, Meridian has dedicated research centers and internists that support high-volume trials for more common conditions, such as migraines and depression. Principal investigators at these sites frequently author articles in prestigious publications — results from a study performed at Meridian were recently published in the Journal of Psychiatric Research.
Meridian provides full recruitment capabilities and procedural continuity to support even the most complex neurological product development programs.
- Alzheimer’s disease
- Epilepsy, idiopathic generalized epilepsy (IGE)
- Huntington’s disease
- Ischemic stroke
- Mild cognitive impairment (MCI)
- Multiple sclerosis (MS), Relapsing-remitting MS
- Muscular dystrophy
- Organic brain syndrome
- Pain management
- Parkinson’s disease
- Tourette syndrome